Article Data

  • Views 661
  • Dowloads 130

Original Research

Open Access

Use of preoperative and intraoperative parameters for decision making in ovarian preservation in endometrial adenocarcinoma

  • Halise Meltem Batur1
  • Murat Gultekin1,*,
  • Mehmet Coskun Salman1
  • Nejat Ozgul1

1Department of Obstetrics and Gynecology, Hacettepe University Faculty of Medicine, 06100 Altındağ, Ankara, Turkey

DOI: 10.31083/j.ejgo4204115 Vol.42,Issue 4,August 2021 pp.763-768

Submitted: 09 November 2020 Accepted: 14 January 2021

Published: 15 August 2021

*Corresponding Author(s): Murat Gultekin E-mail: mrtgultekin@yahoo.com

Abstract

Objective: To investigate the characteristics of endometrial adenocarcinoma (EC) patients with ovarian metastasis and to define criteria for ovarian preservation by using preoperative and intraoperative parameters. Methods: Clinical and pathological characteristics of patients with EC were reviewed. Following univariate and multivariate analysis to determine factors associated with ovarian metastasis, different sets of criteria were analyzed to determine the subgroup of patients with negligible risk of ovarian metastasis. Results: 725 patients were included. Ovarian involvement was detected in 9.1% of patients. Univariate analysis showed that tumor diameter, grade, histological type, myometrial invasion, peritoneal cytology, lymphovascular space invasion (LVSI), cervical invasion, omental and lymph node metastasis are significantly associated with ovarian metastasis while only LVSI, cervical invasion, omental and lymph node involvement were significant on multivariate analysis. By using preoperative and intraoperative parameters only, no ovarian involvement was seen in patients with endometrioid tumor of any grade without myometrial invasion, patients with grade 1, less than 2 cm endometrioid tumors without deep myometrial invasion and in patients younger than 45 years with grade 1 or 2 endometrioid tumors without deep myometrial invasion. Conclusion: Ovarian involvement in cases of endometrial carcinoma occurs in less than 10% of cases. Ovarin preservation could be considered in cases of endometrioid adenocarcinoma that meet certain preoperative and intraoperative criteria.


Keywords

Endometrial adenocarcinoma; Ovarian metastasis; Oophorectomy; Ovarian preservation

Cite and Share

Halise Meltem Batur,Murat Gultekin,Mehmet Coskun Salman,Nejat Ozgul. Use of preoperative and intraoperative parameters for decision making in ovarian preservation in endometrial adenocarcinoma. European Journal of Gynaecological Oncology. 2021. 42(4);763-768.

References

[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians. 2016; 66: 7–30.

[2] Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians. 2015; 65: 87–108.

[3] Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynecology & Obstetrics. 2009; 105: 103–104.

[4] Cavanagh D, Fiorica JV, Hoffman MS, Durfee J, Nicosia SV. Adenocarcinoma of the endometrium: an ınstitutional review. Cancer Control. 1999; 6: 354–360.

[5] Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. International Journal of Gynecology & Obstetrics. 2018; 143: 37–50.

[6] Gilani Modaress M, Cheraghi F, Zamani N. Ovarian metastasis in endometriod type endometrial cancer. International Journal of Fertility and Sterility. 2011; 5: 148–151.

[7] Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecologic Oncology. 2004; 94: 456–462.

[8] Gu H, Li J, Gu Y, Tu H, Zhou Y, Liu J. Survival 228 impact of ovarian preservation on women with early-stage endometrial cancer: a systematic review and meta-analysis. International Journal of Gynecological Cancer. 2017; 27: 77–84.

[9] Sun C, Chen G, Yang Z, Jiang J, Yang X, Li N, et al. Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis. Fertility and Sterility. 2013; 100: 782–787.

[10] Michelsen TM, Pripp AH, Tonstad S, Tropé CG, Dørum A. Metabolic syndrome after risk-reducing salpingooophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. European Journal of Cancer. 2009; 45: 82–89.

[11] Dørum A, Tonstad S, Liavaag AH, Michelsen TM, Hildrum B, Dahl AA. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecologic Oncology. 2008; 109: 377–383.

[12] Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. American Journal of Obstetrics and Gynecology. 2005; 193: 1640–1644.

[13] Lee TS, Lee J, Kim J, Oh S, Seong SJ, Lee JM, et al. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study. Gynecologic Oncology. 2013; 131: 289–293.

[14] Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. Journal of Clinical Oncology. 2009; 27: 1214–1219.

[15] Lee TS, Kim JW, Kim TJ, Cho CH, Ryu SY, Ryu H, et al. Ovarian preservation during the surgical treatment of early stage endometrial cancer: a nation-wide study conducted by the Korean Gynecologic Oncology Group. Gynecologic Oncology. 2009; 115: 26–31.

[16] Koskas M, Bendifallah S, Luton D, Daraï E, Rouzier R. Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery. Fertility and Sterility. 2012; 98: 1229–1235.

[17] Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecologic Oncology. 2008; 109: 11–18.

[18] Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and followup. International Journal of Gynecological Cancer. 2016; 26: 2–30.

[19] National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. Version 2. 2021. Avaliable at: https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf (Accessed: 30 October 2020).

[20] Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Human Pathology. 1985; 16: 28–34.

[21] Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Atlas of tumor pathology. Bethesda, MD: Armed Forces Institute of Pathology. 1998.

[22] Zhou C, Sun J, Sheng X. Ovarian metastasis from endometrial carcinoma: a report of 22 cases. Zhonghua Zhong Liu Za Zhi. 1998; 20: 65–67. (In Chinese).


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top